Showing 1,501 - 1,520 results of 102,496 for search '(( e point decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.50s Refine Results
  1. 1501
  2. 1502
  3. 1503
  4. 1504

    X-axis shows the MEHP quartiles, and Y-axis shows each hormone level. by Atsuko Araki (641415)

    Published 2014
    “…First quartile (≦5.90 ng/mL) is also compared to the 2nd (5.91–10.39 ng/mL), 3rd (10.40–15.30 ng/mL) and 4th (15.31+ ng/mL) quartile MEHP. …”
  5. 1505
  6. 1506
  7. 1507
  8. 1508
  9. 1509
  10. 1510
  11. 1511
  12. 1512
  13. 1513
  14. 1514
  15. 1515
  16. 1516
  17. 1517
  18. 1518
  19. 1519

    Deseasonalized anomaly time series of temperature ((a), (b)) and precipitation minus evaporation (<em>P</em> − <em>E</em>) changes over the tropical oceans and the tropical land fo... by Chunlei Liu (57542)

    Published 2013
    “…The wet and dry regions are defined as the 30% highest and 70% lowest <em>P</em> − <em>E</em> grid points each month. Data are from the CMIP5 historical and RCP 4.5 simulations (1850–2100) and the AMIP simulations (1979–2008). …”
  20. 1520

    Supplementary Material for: Hyperfunctioning Papillary Thyroid Carcinoma with a <b><i>BRAF</i></b> Mutation: The First Case Report and a Literature Review by Shinkai S. (10260734)

    Published 2021
    “…Subsequent mutational analysis of <i>BRAF</i> (exon 15), <i>TSHR</i> (exons 1–10), <i>GNAS</i> (exons 7–10), <i>EZH1</i> (exon 16), <i>KRAS</i>, <i>NRAS</i>, <i>HRAS</i> (codons 12, 13, and 61), and <i>TERT</i> promoter (C250T and C228T) identified a heterozygous point mutation in <i>BRAF</i> V600E in a tumor tissue sample. …”